Hematology & Oncology Doctors in Seattle, WA Accepting Medicare

214 Hematology & Oncology doctors found. Showing 181 - 200

Dr. Fabiana Ostronoff, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-1000

Dr. Chepsy Cherian Philip, M.D Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-6956

Georgiana K Ellis, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Seattle, WA 98109 Phone: 206-288-7400

Ms. Carmen Julia De Ramon Ortiz, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 253-391-4742

Henry Li, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 904 7th Ave, Seattle, WA 98104 Phone: 206-329-1760

Dr. Nicole M Kuderer, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-1000

Krishna Rangadhamarao Juluri, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-520-5000

Dr. Amir Modarressi, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000

Dr. Hani Hassan Alhashmi, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-849-4694

Dr. Sarah Anne Buckley, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-7222

Thomas W Malpass, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600

Dr. Jill M Johnsen, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-543-3360    Fax: 206-543-3560

Konstantinos Geo Balotis, M.D Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-6956

Dr. Ben Manfai Chue, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 524 12th Ave E Apt 203, Seattle, WA 98102 Phone: 206-686-1266

Carl Anthony Blau, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-4100

Elena G Chiorean, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-1000

Dr. Niranjan Nagraj Rathod, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-6956    Fax: 206-288-1119

Sadaf Qureshi, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5000

Dr. Inga Mandac Rogulj, Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-6956    Fax: 206-288-1119

Nicholas R Burwick, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-288-1000

News Archive

AstraZeneca is developing new PARP inhibitor for treatment of ovarian cancer

The ovarian cancer market is highly active with several promising candidates having reached the late stages of development. Three PARP inhibitors, Lynparza (AstraZeneca), niraparib (Tesaro) and rucaparib (Clovis Oncology), which induce cell death in mutated [BRCA-deficient] cancer cells, have been identified by Datamonitor Healthcare as front runners.

Social distancing policies had little effect on lower income people

A new Boston University School of Public Health study of the first four months of America's coronavirus epidemic, published in the journal Nature Human Behaviour, shows that physical distancing (also called "social distancing") policies had little effect.

UCLA research overturns paradigm about how axons grow during embryonic development

New research by scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA overturns a long-standing paradigm about how axons - thread-like projections that connect cells in the nervous system - grow during embryonic development.

AA Pharma launches Lithium Carbonate SR 300mg for Bipolar Disorder in Canada

AA Pharma Inc., a leading distributor of pharmaceuticals in Canada, is pleased to announce the launch of LITHMAX, a sustained release formulation containing 300mg of lithium carbonate. LITHMAX is indicated in the treatment of manic episodes of Bipolar Disorder, as well as the maintenance treatment for individuals with a diagnosis of Bipolar Disorder.

About 60 percent of SARS-CoV-2 cases in England tied to new variant by the end of December

One new SARS-CoV-2 variant of concern, called 202012/01, started to spread in England in late October. A new study published on the pre-print server medRxiv found that 60 percent of daily COVID-19 cases screened by the Alderley Park Lighthouse Labs were tied to 202012/01, also known as lineage B.1.1.7 or 20B/501Y.V1. This suggests a rapid spread of the new variant across the country.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10(current)
• 11